You are looking at 171 - 180 of 4,537 items for

  • Refine by Access: All x
Clear All
Full access

QIM24-192: Place of Death From Cancer in Episodic Value Based Care Models in a Community Oncology Network

Puneeth Indurlal, Lalan Wilfong, Sharon Hart, Hope Ives, and Jessica Neeb

Full access

QIM24-193: Development and Pilot Testing of a Comprehensive Set of Measures for Organizational Assessment of NCCN Guideline Recommended Genomic Testing

Shellie Ellis, Aaron Katz, Chao Huang, Samuel Boyd, Carolyn Caine, Whitney Onasch, Daniel Farrell, Jeffrey Thompson, Joaquina Baranda, Rashna Madan, Wei Zhang, Zseraldina Ferenczi, and Andrew K. Godwin

Full access

QIM24-194: A Cost Effective, Noninvasive Mutiomics Assay (BCDx) for Diagnostic Accuracy of Bladder Cancer Compares to the Gold Standard of Cytoscopy and Cytology

Thakshila Liyanage and Asel Habarakada Liyanage

Full access

TIP24-196: Efficacy of a Mindfulness-Based Stress Management Program for Allogeneic HCT Caregivers: Trial in Progress

Sierra Washington, Sofia Fonseca, Valerie Yepez, Karen Brandon, Bob Gore, Min-Jang Yang, Sarah Jones, Ranjita Poudel, Maija Reblin, Heather Jim, Joseph Pidala, and Christine Vinci

Full access

TIP24-198: A Multi-Center Phase I Trial of Neratinib and Fam-Trastuzumab Deruxtecan in Advanced Refractory Gastric Cancer Patients

Rima Nakrani, Tanu Singh, Elizabeth Handorf, Katherine R. Alpaugh, and Namrata Vijayvergia

Full access

TIP24-199: Rhenium (Re-186) Obisbemeda {Re-186-Nanoliposome (186RNL)} in Leptomeningeal Metastases [LM] Phase 1/2A Dose Escalation Trial: Update of Initial Safety and Feasibility Through Cohorts 1–4

Norman LaFrance, Andrew Brenner, Priya Kumthekar, Michael Youssef, Ande Bao, Melissa Moore, Joel Michalek, Marc Hedrick, William Phillips, Toral Patel, Jeffrey Weinberg, and John Floyd

Full access

YIA24-001: Spatial Evolution of Immune Cell Dysfunction During Development of Oligometastatic Renal Cell Carcinoma: Secondary Analysis of a Prospective Trial

Chad Tang, Kieko Hara, Alexander D. Sherry, Alejandra G. Serrano, Larisa V. Kostousov, Sharia D. Hernandez, Wei Lu, Li Shen, Amishi Y. Shah, Eric Jonasch, Jose A. Karam, Surena F. Matin, Nizar Tannir, Jing Wang, Pavlos Msaouel, Kanishka Sircar, and Luisa Solis

Full access

YIA24-002: Patients’ Perspectives on Being Treated by Multiple Care Teams for Autologous Transplant/CAR-T Eligible Lymphoma and Multiple Myeloma

Zachary A.K. Frosch, Clark Meshack, Caitlin Meeker, Asya Varshavsky-Yanovsky, Rashmi Khanal, Michael Bromberg, Ashwin Chandar, Emmanuel Quien, Jordan Carter, Shazia K. Nakhoda, Marcus Messmer, Charissa Montgomery, Jason A. Incorvati, Nadia D. Ali, Michael J. Styler, and Carolyn Y. Fang

Full access

YIA24-003: A Phase I Study of TAS102 Plus Talazoparib in Advanced Colorectal (CRC) and Esophagogastric (EGC) Adenocarcinomas

Christos Fountzilas, Agnieszka Witkiewicz, Sarah Chatley, Victoria Fitzpatrick, Justin Zonneville, Mohammed Alruwaili, Hanna Rosenheck, Donald Mager, Jianxin Wang, Anuradha Krishnamurthy, Benjamin Switzer, Kristopher Attwood, Igor Puzanov, Renuka Iyer, and Andrei Bakin

Full access

YIA24-004: Liquid Biomarkers of Response to Radium-223 in Metastatic Prostate Cancer

Shuang George Zhao, Grace Blitzer, Jamie Sperger, Menggang Yu, John Floberg, Marina Sharifi, and Joshua Lang